1 Min Read
Oct 16 (Reuters) - Prometrika Llc-
* Prometrika to coordinate second Phase I trial for MD Anderson’s Institute For Applied Cancer Science Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.